天新药业
(603235)
| 流通市值：109.66亿 | | | 总市值：109.66亿 |
| 流通股本：4.38亿 | | | 总股本：4.38亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,691,800,924.45 | 1,292,304,287.54 | 1,569,646,261.86 | 1,367,549,220.46 |
| 交易性金融资产 | 116,676,947.86 | 275,241,577.76 | - | 157,771,072.27 |
| 应收票据及应收账款 | 420,079,471.75 | 433,777,286.27 | 374,795,301.27 | 308,924,475.35 |
| 其中：应收票据 | 114,812,037.49 | 121,106,354.99 | 80,829,805.91 | 72,143,736.23 |
| 应收账款 | 305,267,434.26 | 312,670,931.28 | 293,965,495.36 | 236,780,739.12 |
| 应收款项融资 | 31,000,987.73 | 45,143,108.18 | 85,465,214.44 | 24,386,155.95 |
| 预付款项 | 29,068,723.41 | 51,029,439.18 | 31,382,803.19 | 42,023,349.83 |
| 其他应收款合计 | 6,990,754.6 | 5,575,247.47 | 3,033,478.38 | 3,346,188.51 |
| 存货 | 684,882,035.1 | 541,975,772.07 | 569,886,166.72 | 550,735,359.7 |
| 其他流动资产 | 43,059,948.78 | 148,267,553.06 | 148,600,286.84 | 133,191,086.1 |
| 流动资产合计 | 3,023,559,793.68 | 2,793,314,271.53 | 2,782,809,512.7 | 2,587,926,908.17 |
| 非流动资产: | | | | |
| 固定资产 | 2,354,896,279.35 | 2,141,583,176.57 | 2,084,171,028.02 | 1,884,963,170.41 |
| 在建工程 | 740,565,827.65 | 989,733,587.98 | 1,006,684,460.3 | 1,136,115,713.31 |
| 使用权资产 | 12,893,120.51 | 13,248,250.63 | 13,603,380.75 | 2,524,478.46 |
| 无形资产 | 186,422,413.12 | 187,555,015.62 | 188,477,795.97 | 189,891,694.77 |
| 长期待摊费用 | 16,256,079.11 | 17,081,365.05 | 14,731,339.17 | 12,621,536.26 |
| 递延所得税资产 | 90,592,770.08 | 87,725,400.27 | 90,899,762.72 | 84,074,686.34 |
| 其他非流动资产 | 16,323,104.38 | 24,211,935.4 | 8,342,976.74 | 36,167,231.29 |
| 非流动资产合计 | 3,417,949,594.2 | 3,461,138,731.52 | 3,406,910,743.67 | 3,346,358,510.84 |
| 资产总计 | 6,441,509,387.88 | 6,254,453,003.05 | 6,189,720,256.37 | 5,934,285,419.01 |
| 流动负债: | | | | |
| 短期借款 | 133,730,822.28 | 21,622,637.88 | 7,328,415.25 | - |
| 应付票据及应付账款 | 247,881,900.02 | 280,663,078.19 | 312,220,841.5 | 274,363,264.4 |
| 应付账款 | 247,881,900.02 | 280,663,078.19 | 312,220,841.5 | 274,363,264.4 |
| 合同负债 | 17,082,776.57 | 29,877,322.39 | 18,290,685.5 | 11,766,819.31 |
| 应付职工薪酬 | 69,446,782.41 | 46,114,991.96 | 126,040,843.16 | 80,585,975.54 |
| 应交税费 | 35,174,174.4 | 35,015,012.76 | 31,772,817.68 | 31,177,354.32 |
| 其他应付款合计 | 212,211,514.26 | 21,340,010.41 | 14,054,536.06 | 22,743,053.32 |
| 一年内到期的非流动负债 | 77,761,851.98 | 71,346,481.46 | 84,575,056.89 | 26,476,406.71 |
| 其他流动负债 | 56,390,928.92 | 43,752,587.11 | 41,301,930.31 | 25,491,192.28 |
| 流动负债合计 | 849,680,750.84 | 549,732,122.16 | 635,585,126.35 | 472,604,065.88 |
| 非流动负债: | | | | |
| 长期借款 | 273,486,381.44 | 313,211,509.42 | 299,839,774.71 | 344,702,551.86 |
| 租赁负债 | 12,561,340.2 | 12,582,566.53 | 13,175,725.98 | 740,229.74 |
| 递延收益 | 309,282,661 | 315,406,090.47 | 324,602,519.94 | 330,996,497.12 |
| 非流动负债合计 | 595,330,382.64 | 641,200,166.42 | 637,618,020.63 | 676,439,278.72 |
| 负债合计 | 1,445,011,133.48 | 1,190,932,288.58 | 1,273,203,146.98 | 1,149,043,344.6 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 437,780,000 | 437,780,000 | 437,780,000 | 437,780,000 |
| 资本公积 | 2,001,805,366.59 | 2,001,805,366.59 | 2,001,805,366.59 | 2,001,805,366.59 |
| 减:库存股 | 60,014,480.99 | 60,014,480.99 | 60,014,480.99 | 60,014,480.99 |
| 盈余公积 | 218,890,000 | 218,890,000 | 218,890,000 | 218,890,000 |
| 未分配利润 | 2,398,037,368.8 | 2,465,059,828.87 | 2,318,056,223.79 | 2,186,781,188.81 |
| 归属于母公司股东权益合计 | 4,996,498,254.4 | 5,063,520,714.47 | 4,916,517,109.39 | 4,785,242,074.41 |
| 股东权益合计 | 4,996,498,254.4 | 5,063,520,714.47 | 4,916,517,109.39 | 4,785,242,074.41 |
| 负债和股东权益合计 | 6,441,509,387.88 | 6,254,453,003.05 | 6,189,720,256.37 | 5,934,285,419.01 |
| 公告日期 | 2026-08-29 | 2026-04-30 | 2026-04-24 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |